PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 12, 2020Diabetes Technology & Therapeutics122 citations

Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets

View Full Paper
LMLaurel H. MesserMTMolly L. TanenbaumPCPaul Cook

Key Points

Key points are not available for this paper at this time.

Abstract

Background: Adolescents with diabetes have the highest A1cs of all age groups. Diabetes devices (insulin pumps and continuous glucose monitors CGM) can improve glycemic outcomes, and although the uptake of devices has increased, they remain underutilized in this population. This study characterizes adolescent-reported barriers to diabetes device use to determine targets for clinician intervention. Methods: We surveyed 411 adolescents with type 1 diabetes (mean age 16.30 ± 2.25 years) on barriers to diabetes device use, technology use attitudes (general and diabetes specific), benefits and burdens of CGM, self-efficacy for diabetes care, diabetes distress, family conflict, and depression. We characterize barriers to device uptake; assess demographic and psychosocial differences in device users, discontinuers, and nonusers; and determine differences in device use by gender and age. Results: The majority of adolescents used an insulin pump (n = 307, 75%) and more than half used CGM (n = 225, 55%). Cost/insurance-related concerns were the most commonly endorsed barrier category (61%) followed by wear-related issues (58.6%), which include the hassle of wearing the device (38%) and dislike of device on the body (33%). Adolescents who endorsed more barriers also reported more diabetes distress (P = 0.003), family conflict (P = 0.003), and depressive symptoms (P = 0.014). Pump and CGM discontinuers both endorsed more barriers and more negative perceptions of technology than current users, but reported no difference from device users in diabetes distress, family conflict, or depression. Gender was not related to the perceptions of devices. Conclusions: Clinicians can proactively assess attitudes toward diabetes technology and perceptions of benefits/burdens to encourage device uptake and potentially prevent device discontinuation among adolescents.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Messer et al. (2020) studied this question.

synapsesocial.com/papers/69debee95e217d93a55584b1https://doi.org/10.1089/dia.2019.0509
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring2019 · 58 citations
  2. 2Updated and Revised Diabetes Family Conflict Scale2007 · 258 citations
  3. 3Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit2009 · 69 citations
  4. 4Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes2011 · 129 citations
  5. 5Evaluation of the Patient Health Questionnaire-9 Item for Detecting Major Depression Among Adolescents2010 · 832 citations